Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06116903 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes

Study acronym: ExoGLIE
StatusRecruiting
PhaseNot applicable
Started2024-04-11
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 13, 2024 (before its estimated May 15, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2024-12-10
Not Yet Recruiting→Recruiting Study Status, Oversight, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2023-12-15→confirmed 2024-04-11
2023-10-31
Original filing
The purpose of this pilot study is that exosomes constitute a more interesting support for analyzes allowing a broader screening of molecular alterations to be carried out with more reliable, more sensitive and more efficient results than the reference Foundation One Liquid CDx test.
Trial Details
NCT Number NCT06116903
Lead Sponsor University Hospital, Limoges
Conditions Glioma
Enrollment 60 participants
Start Date 2024-04-11
Primary Completion 2025-05-15 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2024-12-13